# A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors

> **NCT00264472** · PHASE1 · SUSPENDED · sponsor: **Adherex Technologies, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** ADH300004

## Key facts

- **NCT ID:** NCT00264472
- **Lead sponsor:** Adherex Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2006-01
- **Primary completion:** 2009-06
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** Lack of funds
- **Last updated:** 2008-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264472, "A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00264472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*